US & Europe Gene Editing Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - COVID-19 Impact and Global Analysis by Technology (CRISPR, TALEN, Antisense, Zinc Finger Nucleases (ZFNs), and Others), Product and Services (Reagents and Consumables, Instruments, and Others), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), End User (Pharmaceutical & Biotechnology Companies, Academic and Research Institutes, Clinical Research Organizations, and Others), and Geography

No. of Pages: 146    |    Report Code: BMIRE00028808    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
US & Europe Gene Editing Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. US & Europe Gene Editing Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. US & Europe Gene Editing Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Technological advancements in CRISPR technology
  • 5.1.2 Rising focus on personalized medicine
  • 5.1.3 Growing funding for gene therapy research
5.2 Market Opportunities
  • 5.2.1 Expanding research in gene therapies for inherited diseases
  • 5.2.2 Rising investment in gene editing clinical trials
  • 5.2.3 Growing regulatory support for gene-editing applications
5.3 Future Trends
  • 5.3.1 Rising use of CRISPR technology in clinical applications
  • 5.3.2 Increased focus on gene therapies for rare diseases
  • 5.3.3 Technological advancements in precision medicine
5.4 Impact of Drivers and Restraints

6. US & Europe Gene Editing Market Regional Analysis

6.1 US & Europe Gene Editing Market Overview
6.2 US & Europe Gene Editing Market Revenue 2020-2030 (US$ Million)
6.3 US & Europe Gene Editing Market Forecast Analysis

7. US & Europe Gene Editing Market Analysis – by Technology

7.1 CRISPR
  • 7.1.1 Overview
  • 7.1.2 CRISPR: US & Europe Gene Editing Market – Revenue and Forecast to 2031 (US$ Million)
7.2 TALEN
  • 7.2.1 Overview
  • 7.2.2 TALEN: US & Europe Gene Editing Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Antisense
  • 7.3.1 Overview
  • 7.3.2 Antisense: US & Europe Gene Editing Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Zinc Finger Nucleases
  • 7.4.1 Overview
  • 7.4.2 Zinc Finger Nucleases: US & Europe Gene Editing Market – Revenue and Forecast to 2031 (US$ Million)

8. US & Europe Gene Editing Market Analysis – by Product and Services

8.1 Reagents and Consumables
  • 8.1.1 Overview
  • 8.1.2 Reagents and Consumables: US & Europe Gene Editing Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Instruments
  • 8.2.1 Overview
  • 8.2.2 Instruments: US & Europe Gene Editing Market – Revenue and Forecast to 2030 (US$ Million)

9. US & Europe Gene Editing Market Analysis – by Application

9.1 Cell Line Engineering
  • 9.1.1 Overview
  • 9.1.2 Instruments: US & Europe Gene Editing Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Genetic Engineering
  • 9.2.1 Overview
  • 9.2.2 Instruments: US & Europe Gene Editing Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Diagnostic Applications
  • 9.3.1 Overview
  • 9.3.2 Instruments: US & Europe Gene Editing Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Drug Discovery
  • 9.4.1 Overview
  • 9.4.2 Instruments: US & Europe Gene Editing Market – Revenue and Forecast to 2030 (US$ Million)

10. US & Europe Gene Editing Market – United State Analysis

10.1 Europe
  • 10.1.1 US & Europe Gene Editing Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.1.1.1 US & Europe Gene Editing Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 UK: US & Europe Gene Editing Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 UK: US & Europe Gene Editing Market Breakdown, by Technology
    • 10.1.1.1.2 UK: US & Europe Gene Editing Market Breakdown, by Product and Services
    • 10.1.1.1.3 UK: US & Europe Gene Editing Market Breakdown, by Application
  • 10.1.1.2 Germany: US & Europe Gene Editing Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 Germany: US & Europe Gene Editing Market Breakdown, by Technology
    • 10.1.1.2.2 Germany: US & Europe Gene Editing Market Breakdown, by Product and Services
    • 10.1.1.2.3 Germany: US & Europe Gene Editing Market Breakdown, by Application
  • 10.1.1.3 France: US & Europe Gene Editing Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 France: US & Europe Gene Editing Market Breakdown, by Technology
    • 10.1.1.3.2 France: US & Europe Gene Editing Market Breakdown, by Product and Services
    • 10.1.1.3.3 France: US & Europe Gene Editing Market Breakdown, by Application
  • 10.1.1.4 Russia: US & Europe Gene Editing Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.4.1 Russia: US & Europe Gene Editing Market Breakdown, by Technology
    • 10.1.1.4.2 Russia: US & Europe Gene Editing Market Breakdown, by Product and Services
    • 10.1.1.4.3 Russia: US & Europe Gene Editing Market Breakdown, by Application
  • 10.1.1.5 Italy: US & Europe Gene Editing Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.5.1 Italy: US & Europe Gene Editing Market Breakdown, by Technology
    • 10.1.1.5.2 Italy: US & Europe Gene Editing Market Breakdown, by Product and Services
    • 10.1.1.5.3 Italy: US & Europe Gene Editing Market Breakdown, by Application
  • 10.1.1.6 Rest of Europe : US & Europe Gene Editing Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.6.1 Rest of Europe : US & Europe Gene Editing Market Breakdown, by Technology
    • 10.1.1.6.2 Rest of Europe : US & Europe Gene Editing Market Breakdown, by Product and Services
    • 10.1.1.6.3 Rest of Europe : US & Europe Gene Editing Market Breakdown, by Application
10.2 United State
  • 10.2.1 US & Europe Gene Editing Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.2.1.1 US & Europe Gene Editing Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 United State: US & Europe Gene Editing Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.1.1 United State: US & Europe Gene Editing Market Breakdown, by Technology
    • 10.2.1.1.2 United State: US & Europe Gene Editing Market Breakdown, by Product and Services
    • 10.2.1.1.3 United State: US & Europe Gene Editing Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. US & Europe Gene Editing Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Thermo Fisher Scientific Inc.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Merck KGaA
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Lonza Group AG
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Horizon Discovery Group plc.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 INTEGRATED DNA TECHNOLOGIES, INC.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 GenScript Biotech Corporation
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 New England Biolabs
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Eurofins Scientific SE
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 CRISPR Therapeutics
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Editas Medicine Inc
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments
13.11 ElevateBio LLC
  • 13.11.1 Key Facts
  • 13.11.2 Business Description
  • 13.11.3 Products and Services
  • 13.11.4 Financial Overview
  • 13.11.5 SWOT Analysis
  • 13.11.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - US & Europe Gene Editing Market

  1. Thermo Fisher Scientific Inc.
  2. Merck KGaA
  3. Lonza Group AG
  4. Horizon Discovery Group plc.
  5. INTEGRATED DNA TECHNOLOGIES, INC.
  6. GenScript Biotech Corporation
  7. New England Biolabs
  8. Eurofins Scientific SE
  9. CRISPR Therapeutics
  10. Editas Medicine Inc
  11. ElevateBio LLC
us-and-europe-gene-editing-market